Providing a diverse range of perspectives from bullish to bearish, 12 analysts have published ratings on Universal Health Servs UHS in the last three months.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 2 | 5 | 2 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 3 | 0 | 5 | 2 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 1 | 0 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Universal Health Servs, presenting an average target of $181.25, a high estimate of $200.00, and a low estimate of $156.00. This upward trend is apparent, with the current average reflecting a 12.11% increase from the previous average price target of $161.67.
Diving into Analyst Ratings: An In-Depth Exploration
The perception of Universal Health Servs by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Stephen Baxter | Wells Fargo | Raises | Overweight | $200.00 | $195.00 |
| Calvin Sternick | JP Morgan | Raises | Neutral | $182.00 | $144.00 |
| Ben Hendrix | RBC Capital | Raises | Sector Perform | $183.00 | $161.00 |
| Ann Hynes | Mizuho | Raises | Buy | $200.00 | $175.00 |
| Andrew Mok | Barclays | Announces | Equal-Weight | $181.00 | - |
| Sarah James | Cantor Fitzgerald | Maintains | Underweight | $156.00 | - |
| Jamie Perse | Goldman Sachs | Raises | Buy | $189.00 | $170.00 |
| Gary Taylor | TD Cowen | Raises | Market Perform | $181.00 | $140.00 |
| Sarah James | Cantor Fitzgerald | Raises | Underweight | $156.00 | $148.00 |
| Jason Cassorla | Citigroup | Raises | Buy | $193.00 | $170.00 |
| Andrew Mok | UBS | Raises | Neutral | $177.00 | $152.00 |
| Stephen Baxter | Wells Fargo | Announces | Overweight | $177.00 | - |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Universal Health Servs. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Universal Health Servs compared to the broader market.
- Price Targets: Gaining insights, analysts provide estimates for the future value of Universal Health Servs's stock. This comparison reveals trends in analysts' expectations over time.
Capture valuable insights into Universal Health Servs's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Universal Health Servs analyst ratings.
About Universal Health Servs
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two key segments: Acute Care Hospital Services and Behavioral Health Services. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.
Breaking Down Universal Health Servs's Financial Performance
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Over the 3 months period, Universal Health Servs showcased positive performance, achieving a revenue growth rate of 7.44% as of 31 December, 2023. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Net Margin: Universal Health Servs's net margin excels beyond industry benchmarks, reaching 5.84%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Universal Health Servs's ROE excels beyond industry benchmarks, reaching 3.54%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.55%, the company showcases effective utilization of assets.
Debt Management: Universal Health Servs's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.87.
What Are Analyst Ratings?
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
